GKOS Similar Chart Price Prediction
The price of GKOS is predicted to go up -0.09%, based on the high correlation periods with COHU. The similarity of these two price pattern on the periods is 92.9%.
GKOS
COHU
Down: -0.09%Similarity: 92.9%
GKOS Revenue Forecast
GKOS EPS Forecast
GKOS FAQs
What is bull’s view on GKOS?
What is bear's view on GKOS?
What is GKOS revenue forecast for next quarter？
What is GKOS eps forecast for next quarter？
GKOS Analyst's Forecast
Thomas Stephan
Stifel
Strong Buy
2024-12-31
Price Target
$153 → $175
Upside
+16.71%
Stifel analyst Thomas Stephan raised the firm's price target on Glaukos to $175 from $153 and keeps a Buy rating on the shares. The firm says that with the shares at all-time highs, the bar for its survey of 26 iDose-trained ophthalmologists "was lofty." However, the checks "encouragingly met or exceeded" expectations in all key areas, the analyst tells investors in a research note. "Strong" quarterly volume expectations give Stifel greater conviction in a Q4 iDose sales figure in at least the mid-teen millions range, "representing a solid beat." The firm notes its 2025 volume findings "were even more impressive" with a mean of 42 and median 30, suggesting 2024-trained doctors alone can drive upside to Street's $106M 2025 iDose estimate. With moderate contribution from 2025-trained surgeons, total sales in excess of $150M is "highly achievable," notes the firm.
Richard Newitter
Truist Securities
Strong Buy
2024-12-18
Price Target
$152 → $185
Upside
+27.46%
Joanne Wuensch
Citigroup
Hold → Strong Buy
2024-12-11
Price Target
$132 → $162
Upside
+13.37%
